Other
SkylineDx
is a biotechnology company that provides gene signature-based diagnostic testing services for cancer... Read moreSkylineDx
is a biotechnology company that provides gene signature-based diagnostic testing services for cancer... Read moreNews
May 12, 2026
Citybizlist
SkylineDx: SkylineDx Will Share Latest Cutaneous Squamous Cell Carcinoma Findings at 83rd SID Conference
Apr 23, 2026
Citybizlist
SkylineDx: SkylineDx Shares Molecular Diagnostic Insights in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress
Mar 25, 2026
FinanzNachrichten
SkylineDx: SkylineDx: Merlin CP-GEP Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
Mar 05, 2026
FinanzNachrichten
SkylineDx: SkylineDx Launches a Guideline-Informed Risk Assessment Initiative to Support SLNB Decision-Making in Early-Stage Melanoma
Feb 19, 2026
Citybizlist
SkylineDx: NCCN Guidelines Add Merlin CPGEP as the Only GEP Test for Assessing Metastatic Risk in Cutaneous Melanoma
Nov 06, 2025
FinanzNachrichten
SkylineDx: SkylineDx Wins 2025 BioTech Breakthrough Award for "Diagnostics Company of the Year"
Oct 22, 2025
FinanzNachrichten
SkylineDx: SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma
Jul 22, 2025
PR Newswire
Press Release: SkylineDx : SkylineDx's Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
Jun 12, 2025
PR Newswire
Press Release: SkylineDx : Real-world prospective data confirms improved risk stratification in multiple myeloma using SKY92 gene expression profiling
Jun 02, 2025
FinanzNachrichten
SkylineDx: SkylineDx Highlights Merlin Assay's Power to Predict Recurrence Risk of Head and Neck Melanoma Without Sentinel lymph node Biopsy at ASCO 2025
SkylineDx Competitors
1
2
3
4
5
6
7
8
9
10